Meeting
2013 ASCO Annual Meeting
Comparative outcomes of splenectomy and rituximab-based chemotherapy in elderly patients with splenic marginal zone lymphoma.
Authors
Adam J. Olszewski
Alpert Medical School of Brown University, Providence, RI
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 31, 2013 (suppl; abstr 8549)
DOI
10.1200/jco.2013.31.15_suppl.8549
Abstract #
8549
Poster Bd #
47D
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Outcomes of Burkitt lymphoma (BL) managed in academic (Acad) or community (Comm) centers: real-world evidence (RWE) from 30 US sites.
First Author: Adam J. Olszewski
Poster
2015 ASCO Annual Meeting
Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907.
First Author: Hyman B. Muss
Poster
2015 ASCO Annual Meeting
Outcomes and prognostic factors in marginal zone lymphoma: Case Comprehensive Cancer Center cumulative experience of 358 cases.
First Author: Adam Starr
Poster
2014 ASCO Annual Meeting
Inotuzumab ozogamicin (IO) in combination with low-intensity chemotherapy as front-line therapy for older patients (pts) and as salvage therapy for adult with R/R acute lymphoblastic leukemia (ALL).
First Author: Elias Jabbour